Report Detail
Global Friedreich Ataxia Drug Market Research Report 2019
- RnM2745377 |
- 09 January, 2019 |
- Global |
- 128 Pages |
- QYResearch |
- Pharma & Healthcare
This report studies the global Friedreich Ataxia Drug market status and forecast, categorizes the global Friedreich Ataxia Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The major manufacturers covered in this report
Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Shire Plc
STATegics Inc
Voyager Therapeutics Inc
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Clinic
Hospital
Others
The study objectives of this report are:
To analyze and study the global Friedreich Ataxia Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Friedreich Ataxia Drug manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Friedreich Ataxia Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Friedreich Ataxia Drug Manufacturers
Friedreich Ataxia Drug Distributors/Traders/Wholesalers
Friedreich Ataxia Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Friedreich Ataxia Drug market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents
Global Friedreich Ataxia Drug Market Research Report 2018
1 Friedreich Ataxia Drug Market Overview
- 1.1 Product Overview and Scope of Friedreich Ataxia Drug
- 1.2 Friedreich Ataxia Drug Segment by Type (Product Category)
- 1.2.1 Global Friedreich Ataxia Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
- 1.2.2 Global Friedreich Ataxia Drug Production Market Share by Type (Product Category) in 2017
- 1.2.3 ADVM-063
- 1.2.3 AGIL-FA
- 1.2.5 BHV-4157
- 1.2.6 BVA-202
Others
- 1.3 Global Friedreich Ataxia Drug Segment by Application
- 1.3.1 Friedreich Ataxia Drug Consumption (Sales) Comparison by Application (2013-2025)
- 1.3.2 Clinic
- 1.3.3 Hospital
- 1.3.4 Others
- 1.4 Global Friedreich Ataxia Drug Market by Region (2013-2025)
- 1.4.1 Global Friedreich Ataxia Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
- 1.4.2 North America Status and Prospect (2013-2025)
- 1.4.3 Europe Status and Prospect (2013-2025)
- 1.4.4 China Status and Prospect (2013-2025)
- 1.4.5 Japan Status and Prospect (2013-2025)
- 1.4.6 Southeast Asia Status and Prospect (2013-2025)
- 1.4.7 India Status and Prospect (2013-2025)
- 1.5 Global Market Size (Value) of Friedreich Ataxia Drug (2013-2025)
- 1.5.1 Global Friedreich Ataxia Drug Revenue Status and Outlook (2013-2025)
- 1.5.2 Global Friedreich Ataxia Drug Capacity, Production Status and Outlook (2013-2025)
2 Global Friedreich Ataxia Drug Market Competition by Manufacturers
- 2.1 Global Friedreich Ataxia Drug Capacity, Production and Share by Manufacturers (2013-2018)
- 2.1.1 Global Friedreich Ataxia Drug Capacity and Share by Manufacturers (2013-2018)
- 2.1.2 Global Friedreich Ataxia Drug Production and Share by Manufacturers (2013-2018)
- 2.2 Global Friedreich Ataxia Drug Revenue and Share by Manufacturers (2013-2018)
- 2.3 Global Friedreich Ataxia Drug Average Price by Manufacturers (2013-2018)
- 2.4 Manufacturers Friedreich Ataxia Drug Manufacturing Base Distribution, Sales Area and Product Type
- 2.5 Friedreich Ataxia Drug Market Competitive Situation and Trends
- 2.5.1 Friedreich Ataxia Drug Market Concentration Rate
- 2.5.2 Friedreich Ataxia Drug Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Friedreich Ataxia Drug Capacity, Production, Revenue (Value) by Region (2013-2018)
- 3.1 Global Friedreich Ataxia Drug Capacity and Market Share by Region (2013-2018)
- 3.2 Global Friedreich Ataxia Drug Production and Market Share by Region (2013-2018)
- 3.3 Global Friedreich Ataxia Drug Revenue (Value) and Market Share by Region (2013-2018)
- 3.4 Global Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.5 North America Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.6 Europe Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.7 China Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.8 Japan Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.9 Southeast Asia Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 3.10 India Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Friedreich Ataxia Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)
- 4.1 Global Friedreich Ataxia Drug Consumption by Region (2013-2018)
- 4.2 North America Friedreich Ataxia Drug Production, Consumption, Export, Import (2013-2018)
- 4.3 Europe Friedreich Ataxia Drug Production, Consumption, Export, Import (2013-2018)
- 4.4 China Friedreich Ataxia Drug Production, Consumption, Export, Import (2013-2018)
- 4.5 Japan Friedreich Ataxia Drug Production, Consumption, Export, Import (2013-2018)
- 4.6 Southeast Asia Friedreich Ataxia Drug Production, Consumption, Export, Import (2013-2018)
- 4.7 India Friedreich Ataxia Drug Production, Consumption, Export, Import (2013-2018)
5 Global Friedreich Ataxia Drug Production, Revenue (Value), Price Trend by Type
- 5.1 Global Friedreich Ataxia Drug Production and Market Share by Type (2013-2018)
- 5.2 Global Friedreich Ataxia Drug Revenue and Market Share by Type (2013-2018)
- 5.3 Global Friedreich Ataxia Drug Price by Type (2013-2018)
- 5.4 Global Friedreich Ataxia Drug Production Growth by Type (2013-2018)
6 Global Friedreich Ataxia Drug Market Analysis by Application
- 6.1 Global Friedreich Ataxia Drug Consumption and Market Share by Application (2013-2018)
- 6.2 Global Friedreich Ataxia Drug Consumption Growth Rate by Application (2013-2018)
- 6.3 Market Drivers and Opportunities
- 6.3.1 Potential Applications
- 6.3.2 Emerging Markets/Countries
7 Global Friedreich Ataxia Drug Manufacturers Profiles/Analysis
- 7.1 Adverum Biotechnologies Inc
- 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.1.2 Friedreich Ataxia Drug Product Category, Application and Specification
- 7.1.2.1 Product A
- 7.1.2.2 Product B
- 7.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.1.4 Main Business/Business Overview
- 7.2 BioMarin Pharmaceutical Inc.
- 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.2.2 Friedreich Ataxia Drug Product Category, Application and Specification
- 7.2.2.1 Product A
- 7.2.2.2 Product B
- 7.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.2.4 Main Business/Business Overview
- 7.3 Biovista Inc.
- 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.3.2 Friedreich Ataxia Drug Product Category, Application and Specification
- 7.3.2.1 Product A
- 7.3.2.2 Product B
- 7.3.3 Biovista Inc. Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.3.4 Main Business/Business Overview
- 7.4 Cardero Therapeutics Inc
- 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.4.2 Friedreich Ataxia Drug Product Category, Application and Specification
- 7.4.2.1 Product A
- 7.4.2.2 Product B
- 7.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.4.4 Main Business/Business Overview
- 7.5 Catabasis Pharmaceuticals, Inc.
- 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.5.2 Friedreich Ataxia Drug Product Category, Application and Specification
- 7.5.2.1 Product A
- 7.5.2.2 Product B
- 7.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
- 7.5.4 Main Business/Business Overview
- 7.6 Forward Pharma A/S
- 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.6.2 Friedreich Ataxia Drug Product Category, Application and Specification
- 7.6.2.1 Product A
- 7.6.2.2 Product B
- 7.6.3 Forward Pharma A/S Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.6.4 Main Business/Business Overview
- 7.7 Ixchel Pharma LLC
- 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.7.2 Friedreich Ataxia Drug Product Category, Application and Specification
- 7.7.2.1 Product A
- 7.7.2.2 Product B
- 7.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.7.4 Main Business/Business Overview
- 7.8 Pfizer Inc
- 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.8.2 Friedreich Ataxia Drug Product Category, Application and Specification
- 7.8.2.1 Product A
- 7.8.2.2 Product B
- 7.8.3 Pfizer Inc Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.8.4 Main Business/Business Overview
- 7.9 ProQR Therapeutics NV
- 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.9.2 Friedreich Ataxia Drug Product Category, Application and Specification
- 7.9.2.1 Product A
- 7.9.2.2 Product B
- 7.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.9.4 Main Business/Business Overview
- 7.8 RaNA Therapeutics Inc
- 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 7.10.2 Friedreich Ataxia Drug Product Category, Application and Specification
- 7.10.2.1 Product A
- 7.10.2.2 Product B
- 7.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
- 7.10.4 Main Business/Business Overview
- 7.11 Reata Pharmaceuticals Inc
- 7.12 Retrotope Inc
- 7.13 Shire Plc
- 7.14 STATegics Inc
- 7.15 Voyager Therapeutics Inc
8 Friedreich Ataxia Drug Manufacturing Cost Analysis
- 8.1 Friedreich Ataxia Drug Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.1.4 Market Concentration Rate of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.2.1 Raw Materials
- 8.2.2 Labor Cost
- 8.2.3 Manufacturing Expenses
- 8.3 Manufacturing Process Analysis of Friedreich Ataxia Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
- 9.1 Friedreich Ataxia Drug Industrial Chain Analysis
- 9.2 Upstream Raw Materials Sourcing
- 9.3 Raw Materials Sources of Friedreich Ataxia Drug Major Manufacturers in 2017
- 9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.1.3 Marketing Channel Development Trend
- 10.2 Market Positioning
- 10.2.1 Pricing Strategy
- 10.2.2 Brand Strategy
- 10.2.3 Target Client
- 10.3 Distributors/Traders List
11 Market Effect Factors Analysis
- 11.1 Technology Progress/Risk
- 11.1.1 Substitutes Threat
- 11.1.2 Technology Progress in Related Industry
- 11.2 Consumer Needs/Customer Preference Change
- 11.3 Economic/Political Environmental Change
12 Global Friedreich Ataxia Drug Market Forecast (2018-2025)
- 12.1 Global Friedreich Ataxia Drug Capacity, Production, Revenue Forecast (2018-2025)
- 12.1.1 Global Friedreich Ataxia Drug Capacity, Production and Growth Rate Forecast (2018-2025)
- 12.1.2 Global Friedreich Ataxia Drug Revenue and Growth Rate Forecast (2018-2025)
- 12.1.3 Global Friedreich Ataxia Drug Price and Trend Forecast (2018-2025)
- 12.2 Global Friedreich Ataxia Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)
- 12.2.1 North America Friedreich Ataxia Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.2 Europe Friedreich Ataxia Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.3 China Friedreich Ataxia Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.4 Japan Friedreich Ataxia Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.5 Southeast Asia Friedreich Ataxia Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.2.6 India Friedreich Ataxia Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
- 12.3 Global Friedreich Ataxia Drug Production, Revenue and Price Forecast by Type (2018-2025)
- 12.4 Global Friedreich Ataxia Drug Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology/Research Approach
- 14.1.1 Research Programs/Design
- 14.1.2 Market Size Estimation
- 14.1.3 Market Breakdown and Data Triangulation
- 14.2 Data Source
- 14.2.1 Secondary Sources
- 14.2.2 Primary Sources
Summary:
Get latest Market Research Reports on Friedreich Ataxia Drug . Industry analysis & Market Report on Friedreich Ataxia Drug is a syndicated market report, published as Global Friedreich Ataxia Drug Market Research Report 2019. It is complete Research Study and Industry Analysis of Friedreich Ataxia Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
